Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.85
0.292.80%
Last update: Dec 15, 3:03 PM
Comments
Loading...
Amicus Therapeutics (FOLD) Stock Price, Quote, News & History
FOLDNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Amicus Therapeutics (FOLD) stock?
You can purchase shares of Amicus Therapeutics (NASDAQ:FOLD) through any online brokerage.
Who are Amicus Therapeutics (FOLD) competitors?
Other companies in Amicus Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Legend Biotech Corp (NASDAQ:LEGN), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Centessa Pharmaceuticals PLC (NASDAQ:CNTA) and Ascentage Pharma Group International (NASDAQ:AAPG).
What is the forecast, or price target, for Amicus Therapeutics (FOLD) stock?
Amicus Therapeutics has a consensus price target of $23.77.
What is the current price for Amicus Therapeutics (FOLD)?
The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $10.845 last updated December 15, 2025 at 3:03 PM EST.
Does Amicus Therapeutics (FOLD) pay a dividend?
There are no upcoming dividends for Amicus Therapeutics.
When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?
Amicus Therapeutics does not have any upcoming earnings scheduled.
Is Amicus Therapeutics (FOLD) going to split?
There is no upcoming split for Amicus Therapeutics.
What sector and industry does Amicus Therapeutics (FOLD) operate in?
Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
